Dostinex
In stock
0,25mg · 0,5mg
from 58,46 £
In brief
- Dostinex is a prescription-only medicine (POM) in the UK.
- Dostinex is used for the treatment of hyperprolactinaemic disorders and prolactin-secreting pituitary adenomas. The drug acts as a prolactin inhibitor, decreasing serum prolactin levels.
- The usual dose for adults is 0.5 mg per week, which can be titrated up as needed.
- The form of administration is an oral tablet.
- The onset of action can typically be observed within a few days of starting treatment.
- The duration of action is approximately one week, allowing for weekly dosing.
- It is advisable to avoid alcohol while taking Dostinex.
- The most common side effect is nausea.
- Would you like to try Dostinex without a prescription?
Basic Dostinex information
- INN (international nonproprietary name): Cabergoline
- Brand names available in the United Kingdom: Dostinex; generic cabergoline tablets are also available
- ATC code: G02CB03
- Forms and dosages: Tablets 0.5 mg
- Manufacturers in the United Kingdom: Pfizer (Dostinex) and generic manufacturers
- Registration status in the United Kingdom: Prescription-only medicine (POM)
- OTC / Rx classification: Prescription-only medicine (POM)
Everyday use and best practices
Dostinex (cabergoline) is generally administered once or twice weekly, depending on what your healthcare provider recommends. Many patients find it more comfortable to take the medication in the evening, which can reduce the effect of possible side effects such as drowsiness or dizziness during the day. Keeping a regular schedule also makes it easier to stick to the treatment plan. Dostinex can be taken with or without food. Taking it with a meal may help reduce gastrointestinal side effects such as nausea.Safety priorities
Dostinex must not be used by people who are hypersensitive to cabergoline or any of its components, or by those with uncontrolled hypertension. Tell your healthcare provider if you have a history of cardiac valve disorders or fibrotic conditions, as these are important when considering this medicine. When it comes to the activities you can safely perform while on Dostinex, caution is encouraged. Dizziness and fatigue can occur as potential side effects. Therefore, it's advisable to postpone driving or operating heavy machinery until you're familiar with how the medication affects you. This is especially crucial in the initial phases of treatment or after increasing the dosage.Dosage and adjustments
The usual starting dose for adults is 0.5 mg per week, taken as a single dose or divided into two doses. The prescriber adjusts the dose according to the response, checked by prolactin levels. Particular attention should be paid to the elderly or patients with liver impairments. They may require lower starting doses and increased monitoring to ensure safety and effectiveness. In contrast, kidney function doesn't necessitate specific dose adjustments unless severely impacted.What’s inside and how it works
Ingredients overview
The main ingredient in Dostinex is cabergoline, which lowers prolactin secretion in the body. Each tablet contains 0.5 mg of cabergoline.
Mechanism basics explained simply
Cabergoline is a dopamine agonist. This means it mimics the effects of dopamine within the brain, playing a vital role in normalising prolactin levels. The balance it provides can significantly aid in treating hyperprolactinemia and related conditions.
Main indications
Approved uses
Dostinex is licensed in the UK for hyperprolactinaemic disorders, such as galactorrhoea and irregular menstrual cycles, and for prolactin-secreting pituitary adenomas.
Off-label uses in UK clinics
Beyond its licensed use, specialists may occasionally prescribe cabergoline off-label for other conditions. This should always be discussed with a healthcare provider.
Interaction warnings
Food interactions
Alcohol may heighten side effects such as dizziness, so moderation is advisable.
Drug conflicts
Dopamine antagonists such as antipsychotics can oppose the effect of cabergoline, and blood pressure medicines may add to its blood pressure-lowering effect. Suspected side effects can be reported through the Yellow Card scheme.
Alternative choices
For patients unable to use Dostinex, alternatives exist. Bromocriptine and quinagolide are common substitutes for managing hyperprolactinemia, each with its own advantages and disadvantages.
| Alternative | Pros | Cons |
|---|---|---|
| Bromocriptine | Long-established use | Needs more frequent dosing; nausea is common |
| Quinagolide | Taken once daily | Less widely used than cabergoline |
Discuss these options with your healthcare provider to determine the most suitable choice.
Regulation snapshot
Dostinex, containing the active ingredient cabergoline, is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK.
It is therefore supplied only on prescription and is monitored during treatment.
Frequently asked questions
Below are a few frequently asked questions:
-
Can I take Dostinex if I’m pregnant?
Use during pregnancy should only be considered when benefits outweigh risks; it's crucial to consult with a healthcare provider. -
What do I do if I miss a dose?
Take it as soon as remembered unless close to the next dose; double doses should be avoided. -
How long will I need to take Dostinex?
The duration of treatment varies, which is decided by the prescriber and guided by serum prolactin levels.
Guidelines for proper use
Pharmacists in the UK play a vital role in counselling patients regarding the effective administration of Dostinex.
They provide tailored advice on managing side effects and stress the importance of regular check-ups during treatment.
Additionally, the NHS promotes maintaining open communication between patients and healthcare providers, allowing for adjustments as needed.
Practical tips for using Dostinex include:
- Take the medication at the same time each week to maintain consistency.
- Monitor for any side effects and report them to a healthcare professional promptly.
- Engage in regular follow-up appointments to gauge progress, ensuring serum prolactin levels are adequately monitored.
Delivery information
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | North West | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Nottingham | East Midlands | 9–21 days |
| Liverpool | North West | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Newcastle | North East | 9–21 days |
| Bristol | South West | 9–21 days |
| Cardiff | Wales | 9–21 days |
